MARY HALL: Open Payments
NPI 1831505577 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,191 in 158 payments from 14 companies in 2025. Trend: 2023 $52,891 · 2024 $34,608 · 2025 $49,191
Speaker / faculty: $39,400Travel & lodging: $4,235Food & beverage: $3,076Consulting: $2,480
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 93 | $48,023 |
| ABBVIE INC. | 16 | $225 |
| Otsuka America Pharmaceutical, Inc. | 12 | $196 |
| Lundbeck LLC | 8 | $167 |
| Janssen Pharmaceuticals, Inc | 7 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Alkermes, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Sage Therapeutics, LLC | 2 | $46 |
| Janssen Scientific Affairs, LLC | 2 | $45 |
Products named: CAPLYTA, REXULTI, VRAYLAR, SPRAVATO, TRINTELLIX, ARISTADA, COBENFY, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
